Cost effectiveness has its place, but so does common sense

BMJ. 2014 Nov 13:349:g6759. doi: 10.1136/bmj.g6759.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Mass Vaccination / economics*
  • Meningitis, Meningococcal / prevention & control*
  • Meningococcal Vaccines / economics*
  • Models, Economic*

Substances

  • 4CMenB vaccine
  • Meningococcal Vaccines